Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2025-02-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.5bn
reported value
-23.7% vs Q3 2024
37positions
70.5%in top 10
3 new
5 added
10 reduced
4 sold out
vs Q3 2024
Holdings, Q4 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $384.7m26.40% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $109.0m7.48% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $90.6m6.22% | Unchanged |
| PRAXIS PRECISION MEDICINES I PRAX | $76.2m5.23% | Added +283.9k |
| VIRIDIAN THERAPEUTICS INC VRDN | $74.4m5.11% | Unchanged |
| ORUKA THERAPEUTICS INC ORKA | $63.7m4.37% | Added +200.0k |
| SPYRE THERAPEUTICS INC SYRE | $62.5m4.29% | Unchanged |
| PHARVARIS N V PHVS | $61.7m4.24% | Reduced -175.5k |
| KALVISTA PHARMACEUTICALS INC KALV | $52.9m3.63% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $51.2m3.51% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $44.3m3.04% | Added +244 |
| ERASCA INC ERAS | $40.7m2.79% | Unchanged |
| DIANTHUS THERAPEUTICS INC DNTH | $38.0m2.61% | Unchanged |
| UPSTREAM BIO INC UPB | $37.7m2.59% | New |
| ORIC PHARMACEUTICALS INC ORIC | $35.5m2.43% | Unchanged |
| ENGENE HOLDINGS INC COM | $33.6m2.30% | Added +1.5m |
| MERUS N V MRUS | $24.9m1.71% | Reduced -315.6k |
| ASTRIA THERAPEUTICS INC CATB | $22.0m1.51% | Reduced -1.0m |
| CIDARA THERAPEUTICS INC CDTX | $20.6m1.41% | New |
| CULLINAN THERAPEUTICS INC CGEM | $16.8m1.15% | Unchanged |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $16.4m1.13% | Reduced -1.4m |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $16.2m1.11% | Unchanged |
| MERSANA THERAPEUTICS INC COM | $14.7m1.01% | Reduced -1.1m |
| ABIVAX SA ABVX | $9.9m0.68% | Unchanged |
| AQUESTIVE THERAPEUTICS INC AQST | $9.4m0.64% | Reduced -2.9m |
| APPLIED THERAPEUTICS INC APLT | $8.6m0.59% | Added +165.6k |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $7.6m0.52% | Unchanged |
| TERNS PHARMACEUTICALS INC COM | $6.0m0.41% | Reduced -2.3m |
| TAYSHA GENE THERAPIES INC TSHA | $5.6m0.38% | Reduced -5.8m |
| TREVI THERAPEUTICS INC TRVI | $5.2m0.36% | Reduced -2.2m |
| ZURA BIO LTD ZURA | $5.1m0.35% | Unchanged |
| CENTURY THERAPEUTICS INC IPSC | $4.0m0.27% | Reduced -1.4m |
| CASI PHARMACEUTICALS INC CASIF | $2.8m0.19% | Unchanged |
| TENAYA THERAPEUTICS INC TNYA | $2.2m0.15% | Unchanged |
| TENAX THERAPEUTICS INC TENX | $1.3m0.09% | Unchanged |
| GLYCOMIMETICS INC COM | $747.0k0.05% | New |
| INSTIL BIO INC TIL | $633.3k0.04% | Unchanged |
Sold out since Q3 2024
| Security | Value then |
|---|---|
| EDGEWISE THERAPEUTICS INC EWTX | $26.7m1.0m shares |
| ARVINAS INC ARVN | $11.2m454.4k shares |
| ADVERUM BIOTECHNOLOGIES INC ADVM | $10.3m1.5m shares |
| CABALETTA BIO INC CABA | $7.4m1.6m shares |